EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma

Havish S Kantheti, Michael A Hale iD, Shreoshi Pal Choudhuri, Huocong Huang, Xu-Dong Wang iD, Yalda Zolghadri, Giulio Innamorati, Sai Prasada Rao Manikonda iD, Naviya Reddy, Sarthak Reddy, Rahul K Kollipara, Valbona Lumani und 7 weitere

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25126619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Havish S Kantheti und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, UT Southwestern Medical Center, 6001 Forest Park Drive, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatitis, Pancreatic Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, DOD (CDMRP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diagnostic markers are desperately needed for the early detection of pancreatic ductal adenocarcinoma (PDA). We describe sets of markers expressed in temporal order in mouse models during pancreatitis, PDA initiation and progression. Cell type specificity and the differential expression of PDA markers were identified by screening single cell (sc) RNAseq from tumor samples of a mouse model for PDA (KIC) at early and late stages of PDA progression compared to that of a normal pancreas. Candidate genes were identified from three sources: (1) an unsupervised screening of the genes preferentially expressed in mouse PDA tumors; (2) signaling pathways that drive PDA, including the Ras pathway, calcium signaling, and known cancer genes, or genes encoding proteins that were identified by differential mass spectrometry (MS) of mouse tumors and conditioned media from human cancer cell lines; and (3) genes whose expression is associated with poor or better prognoses (PAAD, oncolnc.org). The developmental progression of PDA was detected in the temporal order of gene expression in the cancer cells of the KIC mice. The earliest diagnostic markers were expressed in epithelial cancer cells in early-stage, but not late-stage, PDA tumors. Other early markers were expressed in the epithelium of both early- and late-state PDA tumors. Markers that were expressed somewhat later were first elevated in the epithelial cancer cells of the late-stage tumors, then in both epithelial and mesenchymal cells, or only in mesenchymal cells. Stromal markers were differentially expressed in early- and/or late-stage PDA neoplasia in fibroblast and hematopoietic cells (lymphocytes and/or macrophages) or broadly expressed in cancer and many stromal cell types. Pancreatitis is a risk factor for PDA in humans. Mouse models of pancreatitis, including caerulein treatment and the acinar-specific homozygous deletion of differentiation transcription factors (dTFs), were screened for the early expression of all PDA markers identified in the KIC neoplasia. Prognostic markers associated with a more rapid decline were identified and showed differential and cell-type-specific expression in PDA, predominately in late-stage epithelial and/or mesenchymal cancer cells. Select markers were validated by immunohistochemistry in mouse and human samples of a normal pancreas and those with early- and late-stage PDA. In total, we present 2165 individual diagnostic and prognostic markers for disease progression to be tested in humans from pancreatitis to late-stage PDA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatitisPancreatic NeoplasmsBiomarkers, TumorAnimalsMiceHumansPrognosisGene Expression Regulation, NeoplasticDisease Models, AnimalCell Line, TumorDisease Progression

Stichwörter der Autor:innen

MS mass specPDA early detectioncancer and stromal cell expressiondiagnostic and prognostic markersearly epithelial markershuman PDA cell linesmouse KICscRNAseq screentemporal markers of PDA progression

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pharmacology, UT Southwestern Medical Center, 6001 Forest Park Drive, Dallas, TX 75390, USA.
  • Cancer Discovery (CanDisc) Group, UT Southwestern Medical Center, 6001 Forest Park Drive, Dallas, TX 75390, USA.
  • Texas A&M School of Engineering Medicine, 1020 Holcombe Blvd, Houston, TX 77030, USA.
  • Department of Neuroscience, UT Southwestern Medical Center, Dallas, TX 75390, USA.
  • Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Biochemistry, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390, USA.

ORCID-Profile: Michael A Hale, Xu-Dong Wang, Sai Prasada Rao Manikonda, Pavel Demenkov, Raymond J MacDonald, Rolf A Brekken, Thomas M Wilkie

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • DOD (CDMRP)
  • Anthony Hayes
  • Spherix/AiKido
  • HSK
  • NIH
  • NCI

Zitieren

APA

Kantheti, H. S., Hale, M. A., Pal Choudhuri, S., Huang, H., Wang, X. D., Zolghadri, Y., Innamorati, G., Manikonda, S. P. R., Reddy, N., Reddy, S., Kollipara, R. K., Lumani, V., Girard, L., Bezrukov, Y., Demenkov, P., MacDonald, R. J., Brekken, R. A., Yu, Y., & Wilkie, T. M. (2024). Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126619

Vancouver

Kantheti HS, Hale MA, Pal Choudhuri S, Huang H, Wang XD, Zolghadri Y, et al. Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126619

BibTeX
@article{Kantheti2024,
  author = {Kantheti, Havish S and Hale, Michael A and Pal Choudhuri, Shreoshi and Huang, Huocong and Wang, Xu-Dong and Zolghadri, Yalda and Innamorati, Giulio and Manikonda, Sai Prasada Rao and Reddy, Naviya and Reddy, Sarthak and Kollipara, Rahul K and Lumani, Valbona and Girard, Luc and Bezrukov, Yakov and Demenkov, Pavel and MacDonald, Raymond J and Brekken, Rolf A and Yu, Yonghao and Wilkie, Thomas M},
  title = {Diagnostic and Prognostic Markers for Pancreatitis and Pancreatic Ductal Adenocarcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25126619}
}
Kostenlos starten →